{"name":"Zeltiq Aesthetics","slug":"zeltiq-aesthetics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQQ2wxV1drZ1lXekM0YVp3aS1SNUpSRmlhRGpwZEZuc2JYajdnd3BSanF6QWYzaUFOSTYteVJGdHVBUkZDdnp6SFQzRW1lZ3oxaFdaaXVCS1A0Z3BobUhUWUgtT0g5OUhoSU1uQlVxakxyM0pWTVlvcGR2dV9VN0NqRWNQa1BWTVYtSjZjZXBxTmNzdjVjMEstMnRB?oc=5","date":"2024-11-19","type":"pipeline","source":"Grand View Research","summary":"Europe Energy-based Aesthetic Devices Market Size & Outlook, 2030 - Grand View Research","headline":"Europe Energy-based Aesthetic Devices Market Size & Outlook, 2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQRkUwQ082cmNyT1o0clppOTRTUjFMVXdhbzY3Um1iVVM1RmRvLUpMdUwtNnlSb2NYemNhTGJMUFBTRzhiemZ0SFQyOW52ZmZJWDBEWDBTYTNFSzZTWmg5TFJudWxnbG05UGh0YU5oT3U2R2NlbFJuNVNvZF8tWFN5UFUxbVd1WWsxbVV1TWRqeXFnb0p3?oc=5","date":"2024-07-15","type":"pipeline","source":"Grand View Research","summary":"UK Energy-based Aesthetic Devices Market Size & Outlook, 2030 - Grand View Research","headline":"UK Energy-based Aesthetic Devices Market Size & Outlook, 2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxQWkdIMUo0TjgxNjc5cTl1WFoxTTVvWGlpQUhZY0tBdmswR3BQcXRkdlBXUVI5a1I5NWhGRFZhR2NYdU10MzVMeDVzbDRWVzhmQWdCSER3MW1PU3hQNnYxd2RBWGdvZzhfT1RkVVltUU5pOFV1VjZuLVRUcEE3UWxheW9KcXlDMW5FZ0VlTEc2MWRWMXQycWJ0VXVPSy1FVVFrd3d3Yk0yTXZjZzNLcUVFWFFNZTdxVTFXRzVTc09QMjVSYVVnUjFyNHVkSzA2UQ?oc=5","date":"2021-09-23","type":"pipeline","source":"The Fashion Law","summary":"Linda Evangelista Files Products Liability, Fraud Suit Over Cosmetic Procedure - The Fashion Law","headline":"Linda Evangelista Files Products Liability, Fraud Suit Over Cosmetic Procedure","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPQi1BVVk1bUVYNzJkeWdqekhEaG00LXJsbVJLZmxwNU9iOFZ6YTBYWGRvRGdwQkVQQWFMdng3b1d5dHE5aWFOOGs2OGphLUZwd1FCSEY1RmR5cmpLOTB6Y0VxMlhmLWk5aDVsWXQ3OV9hdFQwblZFYWo4bWhmLXhVUmxSbk5WOUZ0d2xTVWpvcHI?oc=5","date":"2019-10-14","type":"pipeline","source":"BioPharma Dive","summary":"Revance CEO stepping down over ‘misjudgment’ - BioPharma Dive","headline":"Revance CEO stepping down over ‘misjudgment’","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQSVh6NkJNU3BGOU9iclBjeHJsZTNsejFVaVdDNGhZUHJkWGlxdndhamxkYnAzSVR5bVNPdmYzcktySnlsUXVaSWFJY01JMnd1TkI5Sk5mMFkwZXdhR2N2dDNQLVBpaDhoT1ctZTBSaGZaYUw0Y3dwRXpWUkFoVjVSQ0xNMTE1eWI2a1kwRzJTdU92N0RzR3BRX05KYUNzUXJuMDd1ZEZvOWpRQTBxbGdSWXNTSXJzWHlVQWc?oc=5","date":"2019-01-28","type":"pipeline","source":"Fierce Pharma","summary":"Getting Real: Allergan taps Real Housewife to helm new CoolSculpting effort - Fierce Pharma","headline":"Getting Real: Allergan taps Real Housewife to helm new CoolSculpting effort","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNVlA4Ukd0SlhPMjJXRTdkVjJNV2VicUlUSDR1dlFJX2J6dlZISldVdHFUcVIwSDMxOFNYcXZVcnRmTDBtWTVSYkJib1lldW5sdlU5cUF4UG45c0dqQmJQSjBFMHNGVWtKTEJEM2ljSldWdW9YRURna3dqb2ZsVHQyVWtLckZmV0RYcmk2M0EtNlpMTGJzci12ZEJnRnpPRnhuY0NmYV9NOWRZbkVSQjRuNkVHZ05zNGJIWFJndC1lZHotSEZV?oc=5","date":"2018-10-30","type":"pipeline","source":"Fierce Pharma","summary":"Allergan beats on Botox boost, but can migraine sales withstand CGRP rivals? - Fierce Pharma","headline":"Allergan beats on Botox boost, but can migraine sales withstand CGRP rivals?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPQmJwemNVT1lZelhoR3RqcjJQMThxN2JjOGNYWEhZUzlURzJzZHZSYmF6MXJpRlhMVEI4djZPb1AzX19kLU5lX1Q0cHdHSFRTdktvajMtY0lZVmFpWWcyem1YeTMwUm1mV1NWTVJQNVRwMURXNHVncGtiR3JZQkI3YjJ2WEF2anlUbFI2RG9RTXlMdWI4VGV3RDM0RjF5X1RUelhoQVlWckZLQnpvT01v?oc=5","date":"2018-03-27","type":"pipeline","source":"Fierce Pharma","summary":"Doctors expect enthusiasm for Allergan's high-flying Zeltiq to fade: survey - Fierce Pharma","headline":"Doctors expect enthusiasm for Allergan's high-flying Zeltiq to fade: survey","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOR0tseUpfdDNrZlZ2alZDM1BlWlBKTUVVZDJfVm9MNXZ2N014LVhhUEU1T2xuRlJyNWtxMG9zRmt3QzFES2FJdTUteVo4TTlxZENMdHpLVWxoMVl1UXF5WXo0S2dnTnlEOXN6TmNFT3ZZMGR0d0FBdUhnQmZpWU9keGF0dDZ0THNTRGxqMmR1allHR2V1VWFKZTNfa1d5SS1jbVdJ?oc=5","date":"2017-08-07","type":"pipeline","source":"Fierce Pharma","summary":"What's the world's best pharma market? To Allergan's CEO, that one's easy - Fierce Pharma","headline":"What's the world's best pharma market? To Allergan's CEO, that one's easy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPZTJ1Y192VC1KMVVmWXRxLVJYQjNvMDZ5LVk1QzZKMGRweXlwNUZBcWw5cFg5Umk2dGxSLWZhUklNMDFGUmJnWkFlRGNLQkgtY1NfWFdyN0pMcnBzVlg4ZmY1T1d6ZFp2emQ3UGoxSy1tVmhwX29DNWkyOVR1NUcxd3ZvM3VFNGVoUVlzZ2dfc3BvSUNGTzhHX3RiUllmOEhwalJ0OUNXRFRlQnFHX2h4NDlpTUQzb2dVVXZEWUN0cm1Mclk?oc=5","date":"2017-07-12","type":"pipeline","source":"Fierce Pharma","summary":"Allergan CEO comes out against aesthetic treatments for teens in debate-sparking blog post - Fierce Pharma","headline":"Allergan CEO comes out against aesthetic treatments for teens in debate-sparking blog post","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOYkxpdjZGbU9lRmF0X2h5YnN0X2twM1R3cVk2ZFdYYVJnZGZIYzY5TUxLejROOTZwRTNOT09HX2JmU1dmUENnMHlzbE1WQlJHV1hDbnRsdWpPdHdnZXBRSkM3WUNEc2VfTGQ0RlZ0RFlWUUNVUmtrWnV5ZTdBSUVCbmEyS0RyX25ReHAwY0FfUkZTT19JVEd3OHJyZw?oc=5","date":"2017-03-06","type":"pipeline","source":"Pharmaceutical Technology","summary":"February's top stories: Takeda's $5.2bn acquisition, Sanofi €270m cell culture facility investment - Pharmaceutical Technology","headline":"February's top stories: Takeda's $5.2bn acquisition, Sanofi €270m cell culture facility investment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQRnRlbl9YNWF4ZV9pc09UX1Fhd0hhZXVleFFOZDhwT2RZdUlYa3luZ2xiaWw0V0docjFHV2tSZHZlYzFWYU5MUXJuUDNQVGVvcFVFMkRHWjJMTFVrazJvZ1hSUHEzMkxRTkRKWmNDTUpNNkZGSmZvQ0dreG9oWlZJcEt5OHlLYVd1aTVDTw?oc=5","date":"2017-02-13","type":"deal","source":"drugdeliverybusiness.com","summary":"Allergan acquires Zeltiq Aesthetics in $2.48B deal - drugdeliverybusiness.com","headline":"Allergan acquires Zeltiq Aesthetics in $2.48B deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9aQzlpSzVIcE1sLUVMXzRHMHVNcUN1dXBwVDNQU2hSNklVenFGcTFsTXpEc2hockxiZmlVZ2ZFaXhpRm5RZW9jVGZpNnYxOHNFcm91SDhsVlBtTDM0cTlUMWs2QUt5dFFPRXQxME53?oc=5","date":"2017-02-13","type":"deal","source":"Business Insider","summary":"Allergan is buying a fat-freezing company for $2.5 billion - Business Insider","headline":"Allergan is buying a fat-freezing company for $2.5 billion","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}